| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-270-10 | 68083-270 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20171107 | N/A | ANDA | ANDA210123 | Gland Pharma Limited | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (68083-270-10) / 20 mL in 1 VIAL (68083-270-01) |
| 70700-186-23 | 70700-186 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20210813 | N/A | ANDA | ANDA210123 | Xiromed LLC | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (70700-186-23) / 10 mL in 1 VIAL (70700-186-22) |
| 68083-269-10 | 68083-269 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20171107 | N/A | ANDA | ANDA210123 | Gland Pharma Limited | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (68083-269-10) / 10 mL in 1 VIAL (68083-269-01) |
| 70700-187-23 | 70700-187 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20210813 | N/A | ANDA | ANDA210123 | Xiromed LLC | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (70700-187-23) / 20 mL in 1 VIAL (70700-187-22) |
| 68001-524-30 | 68001-524 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20220218 | N/A | ANDA | ANDA210123 | BluePoint Laboratories | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (68001-524-30) / 10 mL in 1 VIAL (68001-524-28) |
| 68001-524-31 | 68001-524 | HUMAN PRESCRIPTION DRUG | Fluorouracil | Fluorouracil | INJECTION, SOLUTION | INTRAVENOUS | 20220218 | N/A | ANDA | ANDA210123 | BluePoint Laboratories | FLUOROURACIL | 50 mg/mL | 10 VIAL in 1 CARTON (68001-524-31) / 20 mL in 1 VIAL (68001-524-29) |